Italy, Switzerland, Austria freeze sales of Novartis flu vaccines

October 24, 2012

Italian, Swiss and Austrian authorities on Wednesday halted the sale of flu vaccines made by Swiss pharmaceutical giant Novartis.

The Italian said it has banned the sale and use of several flu vaccines produced by Novartis pending tests into possible side-effects.

"The health ministry and the Italian medicines agency (AIFA) have decided to take the precaution of banning immediately the use of the vaccines" Aggripal, Fluad and Influpozzi, it said.

On the basis of information supplied by Novartis, AIFA "has decided that it is necessary to carry out further tests regarding the quality and the safety" of the vaccines, which "can produce collateral effects," the statement said.

In Switzerland, the national drug agency Swissmedic said it was ordering the "immediate halt of deliveries from Novartis," due to "possible ".

The alarm was raised after white particles were seen in syringes carrying the vaccines, Swissmedic said, stressing that they could be nothing more than little of the vaccine's components.

The Swiss decision affects some 160,000 , Swissmedic said, adding that it was unclear whether the problem affected vaccines already available in Switzerland.

The freeze on sales of the vaccines and their use was "a simple precaution" and those who had already been vaccinated for the flu "had nothing to worry about", it added.

In Austria, a spokeswoman for Novartis's Austrian subsidiary said that "further deliveries of the Novartis flu vaccines were stopped today (Wednesday)."

She added that the move was a precautionary measure following the moves by Italy and Switzerland.

stu-ide-nl/har

In their statement explaining the freeze on vaccine imports, Italian authorities said they had "decided that it is necessary to carry out further tests regarding the quality and the safety" of the vaccines.

burs/har

In Austria, a spokeswoman for Novartis's Austrian subsidiary said that "further deliveries of the Novartis flu vaccines were stopped today (Wednesday)."

She added that the move was a precautionary measure following similar decisions by Italy and Switzerland.

Explore further: New development could increase flu vaccine supply

Related Stories

New development could increase flu vaccine supply

June 2, 2011
(Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed a new adjuvant, or compound ...

Recommended for you

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Introduction is different, but top medications for opioid addiction equally effective

November 14, 2017
With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.